SHAREHOLDERS' EQUITY - Stock option activity (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Number of Stock Options | ||
| Outstanding, beginning of period | 4,405,000 | 4,725,000 |
| Exercised | (400,000) | (50,000) |
| Cancelled/Expired | (300,000) | (270,000) |
| Outstanding, end of period | 3,705,000 | 4,405,000 |
| Exercisable, end of period | 3,705,000 | 4,363,333 |
| Non-vested, end of period | 41,667 | |
| Weighted Average Exercise Price | ||
| Outstanding, beginning of period (in dollars per share) | $ 1.24 | $ 1.18 |
| Exercised (in dollars per share) | 0.83 | 0.07 |
| Cancelled/Expired (in dollars per share) | 0.83 | 0.42 |
| Outstanding, end of period (in dollars per share) | 1.32 | 1.24 |
| Exercisable, end of period (in dollars per share) | $ 1.32 | 1.24 |
| Non-vested, end of period (in dollars per share) | $ 1.2 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|